Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Bimervax“
Suchtreffer
Begriffe & Kennungen
Bimervax · 4.8 · The safety of BIMERVAX XBB.1.16 is inferred from the safety data of the BIMERVAX (original, heterodimer B.1.35
Eintrag öffnenBimervax · 4.8 · The safety of BIMERVAX XFG.1.1 is inferred from safety data of BIMERVAX (original, heterodimer B.1.351 and B.1
Eintrag öffnenBimervax · 4.8 · The safety of a booster dose of BIMERVAX XBB.1.16 was assessed in an ongoing phase 2b/3 clinical trial in indi
Eintrag öffnenBimervax · 4.8 · The safety of a booster dose of BIMERVAX XBB.1.16 was assessed in an ongoing phase 2b/3 clinical trial in indi
Eintrag öffnenBimervax · 4.8 · The safety of a booster dose of BIMERVAX XBB.1.16 was assessed in an ongoing phase 2b/3 clinical trial in indi
Eintrag öffnenBimervax · 4.8 · The safety of a booster dose of BIMERVAX in adolescents aged 12 through 17 years is based on safety data from
Eintrag öffnenBimervax · 4.8 · The safety of a booster dose of BIMERVAX in adolescents aged 12 through 17 years is based on safety data from
Eintrag öffnenBimervax · 4.8 · The safety of a booster dose of BIMERVAX in adolescents aged 12 through 17 years is based on safety data from
Eintrag öffnenBimervax · 4.8 · The safety of a booster dose of BIMERVAX in adolescents aged 12 through 17 years is based on safety data from
Eintrag öffnenBimervax · 4.8 · The safety of an additional booster dose of BIMERVAX as a fourth dose was assessed in 288 individuals, 18 year
Eintrag öffnenBimervax · 4.8 · The safety of an additional booster dose of BIMERVAX as a fourth dose was assessed in 288 individuals, 18 year
Eintrag öffnenBimervax · 4.8 · The safety of an additional booster dose of BIMERVAX as a fourth dose was assessed in 288 individuals, 18 year
Eintrag öffnenBimervax · 4.8 · The safety of an additional booster dose of BIMERVAX as a fourth dose was assessed in 288 individuals, 18 year
Eintrag öffnenBimervax · 4.8 · The safety profile presented below is based on pooled safety data generated in two phase 2b and phase 3 clinic
Eintrag öffnenBimervax · 4.8 · The safety profile presented below is based on pooled safety data generated in two phase 2b and phase 3 clinic
Eintrag öffnenBimervax · 4.8 · The safety profile presented below is based on pooled safety data generated in two phase 2b and phase 3 clinic
Eintrag öffnenBimervax · 4.8 · The safety profile presented below is based on pooled safety data generated in two phase 2b and phase 3 clinic
Eintrag öffnenBimervax · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenBimervax · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenBimervax · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnen